1Q21 Investor Update
22ND CENTURY INVESTMENT HIGHLIGHTS
+$1.3T global addressable market
across tobaccco¹, hemp/cannabis²,
& third plant-based franchise³
▪ VLN® is the first and only reduced nicotine
content cigarette anticipating FDA's Modified Risk
Tobacco Product (MRTP)4 designation
▪ Fully prepared to launch VLN® within 90 days of
authorization; designation is a catalyst for VLNⓇ
brand and tobacco franchise opportunities
▪ Developing new disruptive, proprietary
hemp/cannabis plant lines with stable, higher
yields, and other commercially desirable traits
through accelerated breeding processes
▪ Potential legislative tailwinds including
enactment of reduced nicotine mandate and
legalization of cannabis would open tremendous
revenue opportunities
Clear growth strategy with continuous,
rich pipeline of revenue opportunities
■
Exclusive, pure-play plant biotechnology
core competencies
Creating disruptive, proprietary commercial plant
lines and new intellectual property in tobacco,
hemp/cannabis, and other large
adjacent market
▪ Over 200 issued and pending patents in
plant-based biotechnology applications supports
entry into adjacent high-value markets.
▪ 20+ years of expertise in developing new,
disruptive technologies
1. Foundation for a Smoke Free World; https://www.smokefreeworld.org/wp-content/uploads/2019/08/FSFW Global-Trends-in-Nicotine 6.22.2020.pdf
2. Prohibition Partners; "The Global Cannabis Report - November 2019"
3. Addressable market of third plant-based franchise is based on a global estimate in 2019.
4. Modified Risk Tobacco Product; https://www.fda.gov/tobacco-products/advertising-and-promotion/modified-risk-tobacco-products
Financial strength
▪ Efficient operating model with multiple routes
to market - commercialization, licensing, and
partnership opportunities
▪ Clear path to profitability through
existing platforms, cultivating large adjacent
markets to leverage core technologies for
additional growth
▪ Healthy balance sheet with more than $30M
in cash, including $11.8M additional cash
received from warrants exercised in
Feb/March 2021
22nd Century Group, Inc.
16View entire presentation